RxDoctor Payments Data

Deborah Howard Patton, APRN

Nurse Practitioner · Bradenton, FLNPI 1497783948

Payments from drug & device makers

$1,266in general payments, 2019–2025

Across 62 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$250
  • Lilly USA, LLC$231
  • Pfizer$201
  • Abbott$147
  • Exact Sciences$111
  • Novo Nordisk$102
  • plus $224 from 9 others

What the payments were for

  • Food & beverage$1,266100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,266 in reported general payments places this provider in the 75th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$91,856
Medicare patients
378
Services billed
1,046

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide71$99,687
OzempicSemaglutide37$66,491
JardianceEmpagliflozin18$33,365
EliquisApixaban34$32,392
XareltoRivaroxaban14$15,061
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$13,153
Tresiba Flextouch U-100Insulin Degludec12$7,166
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$5,242
Levothyroxine Sodium366$3,899
SynthroidLevothyroxine Sodium35$3,462
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$3,035
Gabapentin94$2,486
Duloxetine Hcl77$2,121
Rosuvastatin Calcium267$2,102
Estradiol (Once Weekly)Estradiol21$1,912

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$231$99,68771 claims
Novo NordiskOzempic$102$66,49137 claims
PfizerEliquis$201$32,39234 claims
GSKTrelegy Ellipta$45$13,15317 claims
AbbVieSynthroid$37$3,46235 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Bradenton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →